282 related articles for article (PubMed ID: 1627043)
1. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.
Tamminga CA; Thaker GK; Buchanan R; Kirkpatrick B; Alphs LD; Chase TN; Carpenter WT
Arch Gen Psychiatry; 1992 Jul; 49(7):522-30. PubMed ID: 1627043
[TBL] [Abstract][Full Text] [Related]
2. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
3. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
[TBL] [Abstract][Full Text] [Related]
4. Decreased anterior cingulate gyrus metabolic rate in schizophrenia.
Haznedar MM; Buchsbaum MS; Luu C; Hazlett EA; Siegel BV; Lohr J; Wu J; Haier RJ; Bunney WE
Am J Psychiatry; 1997 May; 154(5):682-4. PubMed ID: 9137127
[TBL] [Abstract][Full Text] [Related]
5. Regional brain function in schizophrenia. I. A positron emission tomography study.
Gur RE; Resnick SM; Alavi A; Gur RC; Caroff S; Dann R; Silver FL; Saykin AJ; Chawluk JB; Kushner M
Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982
[TBL] [Abstract][Full Text] [Related]
6. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
[TBL] [Abstract][Full Text] [Related]
7. Cingulate gyrus volume and metabolism in the schizophrenia spectrum.
Haznedar MM; Buchsbaum MS; Hazlett EA; Shihabuddin L; New A; Siever LJ
Schizophr Res; 2004 Dec; 71(2-3):249-62. PubMed ID: 15474896
[TBL] [Abstract][Full Text] [Related]
8. Increased temporal lobe glucose use in chronic schizophrenic patients.
DeLisi LE; Buchsbaum MS; Holcomb HH; Langston KC; King AC; Kessler R; Pickar D; Carpenter WT; Morihisa JM; Margolin R
Biol Psychiatry; 1989 Apr; 25(7):835-51. PubMed ID: 2785820
[TBL] [Abstract][Full Text] [Related]
9. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
[TBL] [Abstract][Full Text] [Related]
10. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging.
Haznedar MM; Buchsbaum MS; Wei TC; Hof PR; Cartwright C; Bienstock CA; Hollander E
Am J Psychiatry; 2000 Dec; 157(12):1994-2001. PubMed ID: 11097966
[TBL] [Abstract][Full Text] [Related]
11. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.
Ho AP; Gillin JC; Buchsbaum MS; Wu JC; Abel L; Bunney WE
Arch Gen Psychiatry; 1996 Jul; 53(7):645-52. PubMed ID: 8660131
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cortical activity in schizophrenia.
Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
[TBL] [Abstract][Full Text] [Related]
13. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.
Kennedy SH; Evans KR; Krüger S; Mayberg HS; Meyer JH; McCann S; Arifuzzman AI; Houle S; Vaccarino FJ
Am J Psychiatry; 2001 Jun; 158(6):899-905. PubMed ID: 11384897
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia.
Mitelman SA; Bralet MC; Mehmet Haznedar M; Hollander E; Shihabuddin L; Hazlett EA; Buchsbaum MS
Brain Imaging Behav; 2018 Apr; 12(2):532-546. PubMed ID: 28425060
[TBL] [Abstract][Full Text] [Related]
15. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
[TBL] [Abstract][Full Text] [Related]
16. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of human limbic responses to nitrous oxide inhalation.
Gyulai FE; Firestone LL; Mintun MA; Winter PM
Anesth Analg; 1996 Aug; 83(2):291-8. PubMed ID: 8694308
[TBL] [Abstract][Full Text] [Related]
18. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography.
al-Mousawi AH; Evans N; Ebmeier KP; Roeda D; Chaloner F; Ashcroft GW
Br J Psychiatry; 1996 Oct; 169(4):509-16. PubMed ID: 8894204
[TBL] [Abstract][Full Text] [Related]
19. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography.
Gur RE; Resnick SM; Gur RC; Alavi A; Caroff S; Kushner M; Reivich M
Arch Gen Psychiatry; 1987 Feb; 44(2):126-9. PubMed ID: 3492983
[TBL] [Abstract][Full Text] [Related]
20. Neuroanatomic correlates of psychopathologic components of major depressive disorder.
Milak MS; Parsey RV; Keilp J; Oquendo MA; Malone KM; Mann JJ
Arch Gen Psychiatry; 2005 Apr; 62(4):397-408. PubMed ID: 15809407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
